In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler

BACKGROUND: Dry powder inhalers (DPIs) require patients to impart sufficient energy through inhalation to ensure adequate dose emission, medication deaggregation, and resultant particle sizes suitable for lung deposition. There is an ongoing debate regarding the level of inspiratory effort, and ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Melanie, Anderson, Martin, Dhand, Rajiv, Patmore, Oonagh, Prime, David, Taylor, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942181/
https://www.ncbi.nlm.nih.gov/pubmed/36695722
http://dx.doi.org/10.1089/jamp.2021.0061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942181/
https://www.ncbi.nlm.nih.gov/pubmed/36695722
http://dx.doi.org/10.1089/jamp.2021.0061

Ejemplares similares